REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoeconomic analysis, which structure and interpretatio...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
Materialtyp: Artigo
Språk:Russo
Publicerad: IRBIS LLC 2015-09-01
Serie:Фармакоэкономика
Ämnen:
pharmacoeconomics
orphan drugs
rare diseases
cost-utility analysis
Länkar:https://www.pharmacoeconomics.ru/jour/article/view/98
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk